scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH
· Real-Time Price · USD
4.00
0.01 (0.25%)
At close: Jun 17, 2025, 10:22 AM
0.25% (1D)
| Bid | 3.99 |
| Market Cap | 211.43M |
| Revenue (ttm) | 41.98M |
| Net Income (ttm) | -90.78M |
| EPS (ttm) | -1.92 |
| PE Ratio (ttm) | -2.09 |
| Forward PE | -14.69 |
| Analyst | Buy |
| Ask | 4.05 |
| Volume | 37,876 |
| Avg. Volume (20D) | 405,882 |
| Open | 4.00 |
| Previous Close | 3.99 |
| Day's Range | 3.90 - 4.04 |
| 52-Week Range | 1.94 - 5.65 |
| Beta | 0.36 |
About SCPH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SCPH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SCPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+28.57%
scPharmaceuticals shares are trading higher after ...
Unlock content with
Pro Subscription
3 months ago
-1.89%
scPharmaceuticals shares are trading higher after the company announced FDA approval for a supplemental new drug application expanding the FUROSCIX indication to include the treatment of edema in patients with chronic kidney disease.
